Researchers Develop Method to Predict When Doctors Will Reject Clinical AI System Responses
Researchers at an academic medical center created a machine learning model that predicts whether physicians will reject responses from a large language model integrated into electronic health records. The model achieved an AUROC of 0.719 by analyzing query content and deployment-specific context like provider type and department. This approach addresses a key gap in AI evaluation by measuring real-world user acceptance rather than just correctness on benchmarks.
A new study published on arXiv describes a deployment-centered evaluation of a clinical LLM system embedded in an academic medical center's electronic health records. Rather than relying on static benchmarks that measure correctness, researchers trained a pre-response classifier to estimate the likelihood that a physician will reject the system's response before it is generated. The model was evaluated prospectively over 4.5 months using actual user feedback from the deployed system. The key finding is that incorporating deployment-specific context—such as provider type, department name, and which language model generated the response—significantly improved prediction accuracy compared to using only query content. The researchers estimate practical applications for these predictions, including triggering guardrails or causing the system to abstain from responding in high-risk scenarios.
What's missing
The study does not provide details on the specific clinical LLM system used, the size of the user feedback dataset, the types of clinical queries evaluated, or how the model's predictions would affect clinical outcomes and physician workflow in practice.
What different sources said
- arXiv cs.AICenter
Deployment-Centered Evaluation: Predicting Query-Level Rejection Risk in a Clinical LLM System
Related
Topology-Aware Thermodynamics Improves DNA Probe Specificity Design
Researchers developed a new framework for designing DNA probes that accounts for the spatial organization of matched sequences, not just overall thermodynamic stability. Traditional methods rely on scalar measures like melting temperature and free energy, which miss how mismatches are distributed along the probe. The approach could improve diagnostic accuracy in applications like HPV detection and gene expression profiling.
Study Identifies Optimal Thermal Dose for Combining Focused Ultrasound with Immunotherapy in Tumors
Researchers used multimodal PET imaging to identify an optimal thermal dose range for focused ultrasound ablation that destroys tumor tissue while preserving conditions for immunotherapy delivery. The study found that excessive heating collapses blood vessels needed for antibody access, while insufficient heating fails to adequately reduce tumor burden. The findings could guide clinical design of combination treatments pairing thermal ablation with immunotherapies.
Plant MSH1 Protein Functions as Mismatch-Directed Nuclease for Organelle Genome Maintenance
Researchers have identified the precise mechanism by which the AtMSH1 protein in Arabidopsis plants recognizes and cleaves DNA mismatches and lesions, preventing mutations in organellar genomes. The protein combines a DNA mismatch recognition module with a nuclease domain that makes staggered cuts at specific positions relative to DNA damage. This discovery explains how plants maintain unusually low mutation rates in their mitochondrial and chloroplast DNA compared to other eukaryotes.